The Trump Administration has launched Operation Trialblazer to shorten that timeline. Drug companies often “err on the side of submitting too much data, conduct[ing] months of unnecessary studies.” Under Operation Trialblazer, Phase 3 now requires one clinical trial instead of two. Regrettably, the administration’s other signature initiative, TrumpRX, has imported drug price controls. They will increase their market share as smaller companies in financial distress either go out of business or are acquired by larger competitors.